| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 57 |
| 1 | VEDOLIZUMAB | 38 |
| 2 | ACETAMINOPHEN | 34 |
| 3 | INFLIXIMAB | 34 |
| 4 | ERGOCALCIFEROL | 32 |
| 5 | INFLIXIMAB-DYYB | 32 |
| 6 | ADALIMUMAB | 29 |
| 7 | PANTOPRAZOLE | 29 |
| 8 | OMALIZUMAB | 27 |
| 9 | METHOTREXATE SODIUM | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMCINONIDE | 1 | 0.0118 |
| 1 | CAMPHOR (SYNTHETIC) AND MENTHOL | 1 | 0.0112 |
| 2 | INFLIXIMAB-DYYB | 32 | 0.0093 |
| 3 | VERAPAMIL HYDROCHLORIDE | 12 | 0.0028 |
| 4 | ACONITUM NAPELLUS, ARSENIC TRIOXIDE, ATROPA BELLADONNA, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS ROOT | 1 | 0.0024 |
| 5 | DESFLURANE | 3 | 0.0017 |
| 6 | INFLIXIMAB-AXXQ | 2 | 0.0017 |
| 7 | CAPTOPRIL | 13 | 0.0014 |
| 8 | FELODIPINE | 14 | 0.0012 |
| 9 | ERGOCALCIFEROL | 32 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 96 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 83 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 63 |
| 3 | Integrin Receptor Antagonist [EPC] | 51 |
| 4 | Provitamin D2 Compound [EPC] | 32 |
| 5 | Proton Pump Inhibitor [EPC] | 30 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 28 |
| 7 | Anti-IgE [EPC] | 27 |
| 8 | Loop Diuretic [EPC] | 26 |
| 9 | Benzodiazepine [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 4 | 0.0010 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Antifibrinolytic Agent [EPC] | 6 | 0.0006 |
| 5 | Integrin Receptor Antagonist [EPC] | 51 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 8 | Paramagnetic Contrast Agent [EPC] | 2 | 0.0004 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 3 | 0.0004 |